APA (7th ed.) Citation

SH, W., YC, L., MC, C., KY, Y., CC, S., BR, W., . . . SE, T. (2025). Efficacy of cefoperazone-sulbactam as a component of combination therapy for carbapenem-resistant Acinetobacter baumannii bloodstream infection in intensive care units: A multicenter retrospective propensity score-matched study. BMC infectious diseases, 25(1), 872. https://doi.org/10.1186/s12879-025-11205-w

Chicago Style (17th ed.) Citation

SH, Wang, et al. "Efficacy of Cefoperazone-sulbactam as a Component of Combination Therapy for Carbapenem-resistant Acinetobacter Baumannii Bloodstream Infection in Intensive Care Units: A Multicenter Retrospective Propensity Score-matched Study." BMC Infectious Diseases 25, no. 1 (2025): 872. https://doi.org/10.1186/s12879-025-11205-w.

MLA (9th ed.) Citation

SH, Wang, et al. "Efficacy of Cefoperazone-sulbactam as a Component of Combination Therapy for Carbapenem-resistant Acinetobacter Baumannii Bloodstream Infection in Intensive Care Units: A Multicenter Retrospective Propensity Score-matched Study." BMC Infectious Diseases, vol. 25, no. 1, 2025, p. 872, https://doi.org/10.1186/s12879-025-11205-w.